论文部分内容阅读
阿德福韦酯(adefovir,ADV)是新一代核苷类抗病毒药物,已经成为治疗乙型肝炎的一线药物,近年来国内外有文献报道ADV的不良反应,现摘要如下。1急性肾小管坏死男,53岁。1997-04行肾移植术时感染HBV病毒,随后开始拉米夫定治疗。因HBV病毒对拉米夫定耐药,2006-10改用ADV(10 mg/d)治
Adefovir (ADV), a new generation of nucleoside antiviral drugs, has become the first-line drug for the treatment of hepatitis B. In recent years, adefovir has been reported in the literature as adverse reactions in ADV. Acute tubular necrosis Male, 53 years old. 1997-04 Infection with HBV after kidney transplantation, followed by lamivudine treatment. Because of the HBV virus resistance to lamivudine, 2006-10 to ADV (10 mg / d) treatment